Atlas Trials

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

Clinical trial NCT07013916 · RECRUITING

Trial details

NCT number
NCT07013916
Sponsor
Queen Mary University of London
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
MASH - Metabolic Dysfunction-Associated SteatohepatitisMASH With FibrosisSteatosis of Liver
Start date
2025-06-30
Primary completion
2027-04-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.